EN
Xiamen SpaceGen Co., Ltd. was established in 2015. It is a national high-tech enterprise introduced by leading entrepreneurial talents in Xiamen's “Double Hundred Plan”. relying on the four core technology platforms of high-throughput sequencing NGS, digital PCR,fluorescence quantitative PCR, and nucleic acid mass spectrometry, the company is committed to providing overall solutions for personalized and accurate tumor diagnosis, including early screening, disease diagnosis, personalized medication guidance, and efficacy monitoring.
100000+
Provide valuable accurate tumor diagnosis services for more than 100,000 tumor patients
5000+
More than 5000 medical institutions, scientific research institutes and enterprises use SpaceGen's overall gene sequencing solution
100+
Serving more than 100 overseas medical institutions
闽公网安备35021202000745